Healthcare Regulatory & Qui Tam Defense Insurance in Connecticut

Connecticut at a glance

State false claims statute

Connecticut False Claims for Medical Assistance Programs Act

Adopted to meet the federal standard qualifying the state for a larger share of recoveries.

Civil audit authority

Department of Social Services, Office of Quality Assurance

Handles Medicaid program-integrity audits and recoupment separate from criminal referral.

Criminal Medicaid fraud unit

Chief State's Attorney's Office Medicaid Fraud Control Unit

Federally certified unit pursuing criminal fraud and patient-abuse cases.

Insurance regulator

Connecticut Insurance Department

Confirm current licensing and filing guidance directly with the department.

A federally-incentivized state statute with its own procedure

Connecticut's False Claims for Medical Assistance Programs Act was adopted to meet the federal standard that qualifies a state for a larger share of False Claims Act recoveries, and it authorizes qui tam relators to sue on the state's behalf in Superior Court. The Attorney General decides whether to intervene, and Connecticut's intervention and relator-share rules should be confirmed independently rather than assumed to track the federal percentages, since state legislatures periodically revisit these figures.

DSS audits and the Medicaid Fraud Control Unit's separate criminal track

The Department of Social Services conducts program-integrity audits and recoupment on Medicaid claims, while the Chief State's Attorney's Office houses the federally certified Medicaid Fraud Control Unit that investigates criminal fraud and patient-abuse allegations. Because DSS recoupment is a civil administrative process and MFCU referral is criminal, a provider disputing an audit finding through the administrative appeal process should not assume that step resolves any parallel criminal exposure.

Research-corridor referral and marketing scrutiny

Connecticut's research and health-system corridor around Hartford and New Haven means referral arrangements between hospital systems, specialty practices, and pharmaceutical or device companies draw attention under both state anti-kickback concepts and federal Stark and Anti-Kickback Statute analysis. Billing audits, exclusion-list screening, and a documented process for reviewing marketing or referral agreements reduce the odds that an isolated arrangement becomes a program-wide inquiry. Civil penalties, restitution, and knowing misconduct remain uninsurable; defense costs tied to responding to subpoenas or audit demands are where coverage is typically relevant.

Statutes and agency practice change; confirm before relying on this page

Connecticut periodically amends relator-share percentages and intervention deadlines under its false claims statute, so counsel should verify the current figures for any live matter.

Who we write this for in Connecticut

Healthcare regulatory defense FAQs for Connecticut